A distinct signaling pathway called TNF- drives the transformation of epithelial cells into aggressive tumor cells. During cancer progression, cells activate their own TNF- program and become invasive ...
The first ever Hippo targeted therapies are currently in clinical trials for human cancers and are showing benefit, which "will hopefully lead to better treatments for many types of epithelial cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results